Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,935.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 230,275
  • Market Cap: £4,293.48m
  • RiskGrade: 125
  • Beta: 0.01

Geographical - by origin

  31-Dec-2231-Dec-2131-Dec-2031-Dec-1931-Dec-18
Revenue
Europe and Rest of the World210.008%189.007%159.007%122.006%116.006%
Middle East and North Africa866.0034%847.0033%770.0033%719.0033%656.0032%
United Kingdom8.00n/a6.00n/a6.00n/a7.00n/a5.00n/a
United States1,433.0057%1,511.0059%1,406.0060%1,359.0062%1,293.0062%
Total 2,517.00100% 2,553.00100% 2,341.00100% 2,207.00100% 2,070.00100% 
 
Profit Before Tax
Unanalysed233.00100%544.00100%558.00100%491.00100%293.00100%
Total 233.00100% 544.00100% 558.00100% 491.00100% 293.00100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  31-Dec-2231-Dec-2131-Dec-2031-Dec-1931-Dec-18
Revenue
Brandedn/an/a669.0026%613.0026%n/an/a542.0026%
Generics672.0027%820.0032%744.0032%n/an/a692.0034%
Injectables1,141.0063%1,053.0041%977.0042%n/an/a826.0040%
Unanalysed704.00n/a11.00n/a7.00n/an/an/a10.00n/a
Total 2,517.00100% 2,553.00100% 2,341.00100% 2,207.00n/a 2,070.00100% 
 
Profit Before Tax
Brandedn/an/an/an/an/an/an/an/a111.0024%
Genericsn/an/an/an/an/an/an/an/a40.009%
Injectablesn/an/an/an/an/an/an/an/a305.0067%
Unanalysed233.00n/a544.00n/a558.00n/an/an/a(163.00)n/a
Total 233.00n/a 544.00n/a 558.00n/a 491.00n/a 293.00100% 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page